Showing results (351-360 of 406) with videos related to
Sort By:
Pageof 41
The Journal of Clinical Investigation|February 1, 1997
Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in miceS Funakoshi, D D Taub, M R Anver, et al.Molecular Immunology|February 13, 2001
Role for CD40-CD40 ligand interactions in the immune response to solid tumoursA B Alexandroff, A M Jackson, T Paterson, et al.Blood|January 1, 1995
Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studiesJ Whang-Peng, T Knutsen, E S Jaffe, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1991
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatmentD L Longo, A Russo, P L Duffey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and managementA Surbone, D L Longo, V T DeVita, et al.Radiology|December 1, 1982
EOE-13 in the detection of hepatosplenic lymphomaJ L Thomas, M E Bernardino, M Vermess, et al.AIDS (London, England)|June 19, 1998
Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patientsB Y Nguyen, M Clerici, D J Venzon, et al.Blood|February 15, 1991
Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemiaR G Steis, J W Smith, W J Urba, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1996
Chemokines and T lymphocyte activation: II. Facilitation of human T cell trafficking in severe combined immunodeficiency miceW J Murphy, Z G Tian, O Asai, et al.Annals of Internal Medicine|May 1, 1984
Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficienciesJ A Kovacs, J W Hiemenz, A M Macher, et al.Pageof 41